US 10172937
Method of treatment of malignant solid tumors with afucosylated anti-FGFR2IIIb antibodies
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 10172937 (Method of treatment of malignant solid tumors with afucosylated anti-FGFR2IIIb antibodies) held by Five Prime Therapeutics, Inc. expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Five Prime Therapeutics, Inc.
- Grant date
- Tue Jan 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K2039/54, A61K2039/545